Funding Opportunities

submenu

Extramural grant review opportunity available

Writing a grant? Need another set of eyes?

The Masonic Cancer Center Science Council can appoint individuals to review cancer center faculty members' grant drafts* or grant ideas in a face-to-face setting or in writing, depending on the stage of grant development. The goal is to improve upon members' success in obtaining grants funded by the NCI, ACS, and other national cancer research organizations.

To request a review, contact Elizabeth Fedie, efedie@umn.edu, 624-0653.

*Members should submit their ideas or abstracts and specific aims one cycle (~3-4 months minimum) before the grant is due. We will usually provide feedback within 1 week.

News and notices

New Topic Areas for FY16: Bladder Cancer, Lymphoma, Pediatric Brain Tumors and Immunotherapy

The FY16 Defense Appropriations Act provides $50 million to the Department of Defense Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research.

The PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY16 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on the Grants.gov website in April and July 2016. Pre-application and application deadlines will be available when the Program Announcements are released.

Learn more about this opportunity


NOT-OD-16-031

This notice informs the biomedical and health services research community of planned changes to the PHS Research Performance Progress Report (RPPR) instructions for all annual non-competing (Type 5) NIH & AHRQ awards that support research activities.

These updates to address Rigor and Transparency will take effect for RPPRs due on or after January 25, 2016.

Updates to NIH & AHRQ Research Performance Progress Reports



NOT-TR-15-020

Notice of Corrections to PAR-15-173 "Pre-Application for Collaborative Innovation Award, CTSA Program (X02)"

Learn more about this notice


Consideration of Sex as a Biological Variable in NIH-funded Research

Sex and gender play a role in how health and disease processes differ across individuals, and consideration of these factors in research studies informs the development and testing of preventive and therapeutic interventions in both sexes.  This notice focuses on NIH's expectation that scientists will account for the possible role of sex as a biological variable in vertebrate animal and human studies.

Learn more about this notice: NOT-OD-15-102


NIH & AHRQ Announce Upcoming Changes to Policies, Instructions and Forms for 2016 Grant Applications

The planned changes focus on the following areas:

  • Rigor and transparency in research
  • Vertebrate animals
  • Inclusion reporting
  • Data safety monitoring
  • Research training
  • Appendices
  • Font requirements
  • Biosketch clarifications

Some of the new policies require additional data collection and updates to application forms, with phase one implemented for due dates on or after Jan. 25th, 2016 and phase two implemented for due dates on or after May 25th, 2016.

Learn more about the upcoming changes for this notice NOT-OD-16-004

 

 

External funding opportunities


AACR NextGen Grants for Transformative Cancer Research
American Association for Cancer Research
​The AACR NextGen Grants for Transformative Cancer Research represent the AACR's flagship funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence.

Funding: The grants provide $450,000 over three years

Key dates:
Letter of intent due September 12, 2016
If invited for full application, due December 19, 2016


 Pancreatic Cancer Action Network-AACR Career Development Award
The Pancreatic Cancer Action Network-AACR Career Development Awards represent a joint effort to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in this field.

Funding: The grants provide $200,000 over two years.

Key dates:

Letter of intent due October 4th, 2016
If invited for full application, due January 17, 2017


Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant

The Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant represents a joint effort to ensure the future leadership of pancreatic cancer research by supporting outstanding early career investigators beginning in their postdoctoral research positions and continuing through their successful transition to independence. Applicants must hold a full-time, mentored research position, have completed their most recent doctoral degree or medical residency within the past five years, and not already have a full-time faculty position.

Funding: The grant provides up to five years of support, for a total of $600,000, consisting of two phases. The initial Mentored Phase is expected to last up to two years, during which time the recipient will receive $75,000 per year while working closely with a mentor(s) to develop a strong research project. During the subsequent three years, the recipient is expected to be in an independent research position and will be funded at $150,000 per year.

Key dates:
Full application due November 15, 2016


 


 RFP:Randy Shaver Cancer Research Fund
The Randy Shaver Cancer Research and Community Fund is seeking proposals from non-profit organizations and other public entities with innovative and creative projects that will result in benefiting Minnesota’s Cancer Community.  This fund’s primary objective is to support organizations, hospitals, research facilities and other public entities that are involved in cancer research, cancer patient aid and cancer oriented community endeavors.

Funding: The Fund will grant over $500,000.00 to groups/researchers that submit proposals.
Key Dates:
Full application due October 31, 2016


 AACR Basic Cancer Research Fellowships
The AACR Basic Cancer Research Fellowships are open to postdoctoral and clinical research fellows working at an academic, medical, or research institution who have completed their most recent doctoral degree or medical residency within the past three years at the start of the grant term. The research proposed for funding may be in any area of basic cancer research.

Funding: The fellowships provide one-year grants of $50,000-$55,000

Key dates:
Letter of intent due October 11, 2016
If invited for full application, due January 18, 2017


 PAR-15-332

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)
As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as the initial development or the significant modification of existing tools for new applications.

Funding: Budgets are limited to $300,000 Direct Costs per year for a maximum of 3 years.

Key Dates:
Full application due November 21, 2016.


Pancreatic Cancer Action Network Translational Research Grant

Supports an independent investigator leading a cross-disciplinary team conducting translational research that has as its endpoint the development of a pancreatic cancer assessment, prevention or treatment modality

Funding: $300,000 over 2 years
Key Dates:
Application due December 1, 2016


 Pancreatic Cancer Action Network – NCI, Frederick National Laboratory for Cancer Research KRAS Travel Scholarship
Provides travel support to a researcher at any career stage, during or after the postdoctoral level, to visit FNLCR to pursue KRAS research that is directly relevant to pancreatic cancer with aims aligned with the RAS Initiative

Funding: Depending on need

Key Dates:
Application deadline is rolling


Pancreatic Cancer Action Network – NCI, Frederick National Laboratory for Cancer Research KRAS Fellowship

Supports a postdoctoral or clinical research fellow to conduct KRAS research that is directly relevant to pancreatic cancer with aims aligned with the RAS Initiative

Funding: $100,000 over two years

Key Dates:
Application deadline is October 27, 2016


 PAR-15-334

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)
As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge.

Funding: Direct costs are limited to $275,000 over a two year period. No more than $200,000 may be requested in any single year.

Key Dates:
Full application due November 21, 2016


PAR-16-411

NCI Outstanding Investigator Award (R35)|
This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.

The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA.

It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.

Funding: Awards will be for $600,000 direct costs per year, plus applicable Facilities and Administrative (F&A) costs to be determined at the time of award.

Key dates:
Full application due November 22, 2016


Call for Proposals: Community-University Partnership Grant Program

The Healthy Foods, Healthy Lives (HFHL) Institute has released its fall 2016 RFP for the Community-University Partnership Grant Program to fund innovative, community-University partnerships that utilize community-engaged research strategies. HFHL is also calling for Letters of Interest for the Faculty Planning Grant Program, designed to fund the development of food, nutrition, and health-related interdisciplinary faculty research teams. Submission deadline is Nov. 18. See HFHL grant opportunities 

The Karen Wyckoff Rein in Sarcoma Foundation 2017 (PDF)
Sarcoma Research Grant Application
The research grants support one of the three major goals of the foundation (research; patient and survivor support; and education) to continue Karen’s vision and must focus on primarily sarcoma (basic, translational, and/or clinical) research.

Funding: $50,000 for one year (cost sharing is encouraged)

Key dates:
Submission Deadline: October 31
Review: November 2016
Funds available starting: March 1, 2017



 2016  SITC-Bristol-Myers Squibb Cancer Immunotherapy Translational Fellowship

Society for Immunotherapy of Cancer
Due to the recent research advances, discoveries, and agent approvals, cancer immunotherapy is quickly emerging as one of the four standards of care for cancer patients. To support the development of the next generation of immunotherapy experts, this two-year award (24 months) aims to provide support for an individual who has an MD or combined MD/PhD and a vested interest in furthering the research and translation of cancer immunotherapy.

Funding: 

Fellowship Period: December 1, 2016 – November 30, 2018
Amount:$200,000 ($100,000 per year for two years)

Key Dates:

Full Application due August 29, 2016


RFP: 2016 Wallin Discovery Fund (pdf)

The Winston and Maxine Wallin Neuroscience Discovery Fund
The Academic Health Center (AHC) is requesting applications to fund creative, pioneering studies in neuroscience for the 6th year. Funds for the present proposal will be distributed through a competitive peer review process.
The purpose of the Fund is to support the research mission of the Medical School and the AHC. Specifically, the fund will advance the work of talented neuroscientists leading innovative, ground-breaking and novel research. The Fund will provide money for early-stage ideas and creative, pioneering projects in neuroscience that otherwise may go unfunded by conventional grant-making bodies. The ultimate goal is that such proposals will lead to new or continued funding through the National Institutes of Health, National Science Foundation or other federal/national agencies. The Fund is particularly interested in applications that align with opportunities for large federal funding initiatives e.g., The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative. The Fund also seeks to support applications from our most promising assistant professors.

Funding: 

Multiple awards will be made via a gift of $500,000.

Key Dates:

Letter of Intent due September 12, 2016.
Full application due 12:00 noon September 26, 2016.
Awards announced December 14, 2016.


2016 Accelerate Clinical Trials (ACT) Grant Competition  

Request for Applications
Free to Breathe - a partnership for lung cancer survival
Free to Breathe is announcing its second year of a grant funding opportunity focused on research to systematically investigate interventions or strategies to increase clinical trial accrual to therapeutic lung cancer clinical trials.
Our goal is to fund pilot research projects that will investigate novel strategies to improve accrual of patients with lung cancer to therapeutic clinical trials by at least 50% within a defined healthcare facility, system, or community. Proposals must have a clear vision about how the pilot project, if successful, can be an expanded to other institutions for validation of the intervention or strategy. The intent of Free to Breathe is to fund projects that will be reproducible and implementable to a wider community.
Applications are sought from independent investigators at U.S. based institutions. Sponsoring institutions need to have demonstrated a solid track record of maintaining open therapeutic lung cancer clinical trials that can support the proposed intervention to increase patient accrual.

Funding:

For 2016, we expect to support up at least one award of $100,000, paid over 2 years.

Key Dates:

Full application due October 28, 2016


BCRP Breakthrough Award Levels 3 and 4 II

Department of Defense (CDMRP)

W81XWH-16-BCRP- BREAKTHROUGH2_FL34
The intent of the Breakthrough Award is to support promising research that has high potential to
lead to or make breakthroughs in breast cancer. Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome.

Funding:

Funding Level 3: Advanced translational studies that have potential for near-term clinical investigation. Small-scale clinical trials may apply.
Funding: Direct costs budgeted may not exceed $2.5M over 4 years ($4M over 4 years for partnering PI option).
Funding Level 4: Large-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer. Near-term clinical impact is expected. PIs are expected to have experience in successfully leading large-scale projects. 
Funding: Direct costs budgeted may not exceed $10M over 4 years.

Key Dates:

Pre-Application due September 14, 2016
Full Application due December 8, 2016



RFA-CA-16-014

Cancer Target Discovery and Development Network (U01)

NIH/NCI
This FOA will continue to support the program "Cancer Target Discovery and Development” (CTD^2, pronounced cee-tee-dee-squared).  CTD^2 is focused on efforts that advance cancer research by bridging the knowledge gap between the rapidly increasing volumes of new data generated by comprehensive molecular characterizations of many cancer types and studies of the underlying etiology of cancer development, progression, and/or metastasis.

Funding:

Budgets up to $750,000 direct costs per year may be requested, for up to 5 years.

Key Dates:

Full Application due October 3, 2016


PA-16-251
Gene Fusions in Pediatric Sarcomas (R01)

NIH/NCI

The overall goal of this funding opportunity announcement (FOA) is to encourage the submission of research grant applications to investigate the molecular mechanisms by which oncogenic fusion genes and their gene products contribute to pediatric sarcoma initiation, progression, and metastasis. Better understanding of the molecular pathways activated by chromosomal translocations in pediatric sarcomas, and their relationship to oncogenesis and tumor progression, can elucidate mechanisms of cancer pathogenesis and potentially lead to novel therapeutics.  

Funding: 

Application budgets are not limited but need to reflect the actual needs of the proposed project. Maximum performance period is 5 years.

Key Dates:

Full Application due October 5, 2016


 


PAR-16-278
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention & Control (R21)

The purpose of this FOA is to provide support for the development of innovative interventions that improve cancer-related health behaviors across diverse racial/ethnic populations. Specifically, this FOA is intended to stimulate research aimed at 1) testing new theories and conceptual frameworks; 2) developing and evaluating novel strategies to improve cancer-related health behaviors; 3) investigating multi-level and multi-behavioral approaches; and 4) utilizing innovative research designs, methodologies, and technologies. The cancer-related health behaviors to be targeted are diet, obesity, physical activity and sedentary behavior, smoking, sleep and circadian dysfunction, alcohol use, and/or adherence to cancer-related medical regimens. Research can involve any aspect of the cancer continuum and any phase of the translational spectrum.

Funding: 

Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.

Key Dates:

Full Application due October 16, 2016


 


NOT-GM-16-111
Notice of Intent to Publish a FOA for the Maximizing Investigators' Research Award for Early Stage Investigators (R35)

The National Institute of General Medical Sciences intends to publish a Funding Opportunity Announcement (FOA) to solicit applications for its Maximizing Investigators' Research Award (MIRA) program initiative.  This FOA will continue pilot testing of the MIRA concept by targeting Early Stage Investigators.  The FOA will be a reissue of RFA-GM-16-003 with the change that New Investigators who are no longer Early Stage Investigators will not be eligible.   Other minor changes are expected to improve the clarity of the announcement.

This Notice is being provided to allow potential applicants sufficient time to develop their applications and to efficiently address the large number of inquiries that have been received regarding NIGMS plans. The Maximizing Investigators' Research Award (MIRA) is a grant to provide support for the program of research in an investigator's laboratory that falls within the mission of NIGMS. The goal of MIRA is to increase the efficiency and efficacy of NIGMS funding.

Funding:

$250,000 direct costs/yr for up to 5 years.

Key Dates:

The FOA is expected to be published in the summer 2016 with an expected application due date in the fall 2016.


Graduate Training in Disparities Research (GTDR)
Susan G. Komen

GTDR Grants are intended to establish and/or to sustain a training program for a minimum of three graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups. Over the past 7 years, Komen has provided funding to outstanding training programs to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research focused on disparities in breast cancer outcomes. Komen supports exceptionally creative training programs for students of diverse backgrounds as a means to support innovative breast disparities research.

Funding:

Up to $135,000 per year, direct costs only, for up to 3 years.

Key Dates:

Full application due September 20, 2016


PAR-16-338
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01)

This funding opportunity encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.

Funding:

Application budgets should reflect the actual needs of the proposed project. The maximum project period is 5 years.

Key Dates:

Full application due October 5, 2016


Graduate Training in Disparities Reasearch (GTDR)
Susan G. Komen

GTDR Grants are intended to establish and/or to sustain a training program for a minimum of three graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups. GTDR Grants will only be a one step process for FY17 and will not require a Letter of Intent. 

Funding:

Up to $135,000 per year, direct costs only, for up to 3 years

Key Dates:

Full application due September 2016.


 


AACR NextGen Grants for Transformative Cancer Research

American Association for Cancer Research
​The AACR NextGen Grants for Transformative Cancer Research represent the AACR's flagship funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence.

Funding:

The grants provide $450,000 over three years

Key dates:

Letter of intent due September 12, 2016


Clinical Consortium Research Site Award
Department of Defense Prostate Cancer Research Program

The Clinical Consortium Research Site Award provides the support to develop and enhance collaborations and resources necessary for a network of organizations to rapidly execute Phase II or Phase II-linked Phase I (Phase I/II) prostate cancer clinical trials. These trials will include investigations of high-impact, novel therapeutic agents or approaches for the management or treatment of prostate cancer, especially as pertaining to the FY16 PCRP overarching challenges. In accordance with PCRP goals, the conduct of Phase I/II trials that incorporate investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer is particularly encouraged.

Funding:

$200,000

Key Dates:

Pre-application deadline: September 15, 2016, 5 p.m. ET
Full application: October 11, 2016, 11:59 p.m. ET


PAR-16-338
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01)

This funding opportunity encourages research on how the healthcare delivery system enhances or inhibits the effectiveness of a provider's recommendation of the adolescent human papillomavirus (HPV) vaccine. Characteristics of the provider, parent/patient, and clinical setting, can all affect whether a provider makes a recommendation, and whether that recommendation results in uptake of the HPV vaccine. This research requires expertise in cancer prevention, adult and childhood behavior, immunization promotion, and healthcare delivery.

Funding:

Application budgets should reflect the actual needs of the proposed project. The maximum project period is 5 years.

Key Dates:

Full application due October 5, 2016


Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment

PAR-16-212 (R01) and PAR-16-213 (R21)

NIH/NCI
This Funding Opportunity Announcement (FOA) encourages transdisciplinary research that will leverage cognitive neuroscience to improve traditional measurement of cognitive impairment following cancer treatment, often referred to as “chemobrain.” A better understanding of the acute- and late-term cognitive changes following exposure to adjuvant chemotherapy and molecularly-targeted treatments, including hormonal therapy, for non-central nervous system tumors can inform clinical assessment protocols with downstream implications for survivorship care plans.

Funding:

(R01) - Maximum project period is 5 years. Application budgets should reflect the actual needs of the proposed project.
(R21) - The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Key Dates:
Full application due date for both the (R01) and (R21) is October 13, 2016.


PAR-16-276

Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection (R01)
Companion FOA: PAR-16-277: R21
This Funding Opportunity Announcement (FOA)  encourages research projects that focus on innovative research in the isolation and characterization of exosomes and their cargo for discovery of predictive biomarkers for risk assessment, detection, diagnosis and prognosis of early cancer. This FOA will promote rigor and reproducibility research in both the isolation of exosomes as well as the computational analysis of the cargo carried in these vesicles.

Funding:

Application budgets are not limited but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.

Key dates:

Full application due October 13, 2016


Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions

PAR-16-202 (R01) and PAR-16-201 (R21)
NIH/NCI
The purpose of this Funding Opportunity Announcement (FOA) is to provide support for innovative and promising intervention research designed to improve smoking cessation outcomes among socioeconomically disadvantaged populations. Specifically, this FOA is intended to stimulate research efforts aimed at the development of smoking cessation interventions that: 1) are targeted to socioeconomically disadvantaged populations, and 2) could be made scalable for broad population impact. Applicants may propose projects that develop and test novel cessation interventions with the potential to be scaled up, as well as projects that focus on enhancing the effectiveness, quality, accessibility, utilization, and cost-effectiveness of currently scaled smoking cessation interventions. This FOA provides funding for up to 2 years for protocol development and early phase, pilot, or exploratory projects.

Funding:

(R01) - Maximum project period is 5 years. Application budgets should reflect the actual needs of the proposed project.
(R21) - The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Key Dates:
Full application due date for both the (R01) and (R21) is October 11, 2016.


Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)

(NOT-OD-15-044)
(PAR-15-075)
National Cancer Institute

Funding:

Standard R01 limits apply

Application Receipt Date(s):

Standard dates apply, by 5:00 PM local time of applicant organization.


PAR-16-411
NCI Outstanding Investigator Award (R35)

This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.
The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA.
 
It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.

Funding:

Awards will be for $600,000 direct costs per year, plus applicable Facilities and Administrative (F&A) costs to be determined at the time of award.

Key dates:

Full application due November 22, 2016


NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

(PAR-15-064)
National Cancer Institute

Funding:

$100,000/yr towards salary; $30,000/yr for other expenses

Application Receipt Date(s):

Multiple dates, see announcement.


 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08)

(PAR-15-060)
National Cancer Institute

Funding:

$100,000/yr towards salary; $30,000/yr for other expenses

Application Receipt Date(s):

Multiple dates, see announcement.


NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)

(PAR-15-062)
National Cancer Institute

Application Receipt Date(s):

Multiple dates, see announcement.

Funding:

$100,000/yr towards salary; $30,000/yr for other expenses


 


National Cancer Institute Program Project Applications (P01)

(PAR-15-023)
National Cancer Institute

Application Receipt Date(s):

Multiple dates, see announcement.

Funding:

Varies. 


Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2015 and 2016 (P50)

(PAR-14-353)
National Cancer Institute

Application Receipt Date(s):

September 22, 2016

Funding:

$2,300,000 total costs/year 


Advancing Interventions to Improve Medication Adherence

PA-14-334 – R01 and PA-14-335 – R21

National Cancer Institute

Application Receipt Date(s):

Multiple dates, see announcement.

Funding:

Standard R01 & R21 limit


Role of the Microflora in the Etiology of Gastro-Intestinal Cancer (R01)

(PAR-14-242)
National Cancer Institute

Application Receipt Date(s):  

See announcement for dates.

Funding:

Standard R01 limits apply 


 


Interventions for Health Promotion and Disease Prevention in Native American Populations (R01)

(PAR-14-260)
National Cancer Institute

Application Receipt Date(s):

See announcement for dates.

Funding:

Standard R01 limits apply.


Genomic Resource Grants for Community Resource Projects (U41)

(PAR-14-191)
National Cancer Institute

Funding:

5 years of funding.  Application budgets are not limited, but should reflect the needs of the proposed project.

Application Receipt Date(s):

September 25, 2016; January 25, 2017


Behavioral Interventions to Address Multiple Chronic Health Conditions in Primary Care (R01)

(PA-14-114)
National Cancer Institute

Funding:

Standard R01 limits apply.

Application Receipt Date(s):

Multiple dates, see announcement.


Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)

(PAR-14-013)
National Cancer Institute

Funding:

Standard R21 limits apply

Deadline:

See announcement for dates.


Quantitative Imaging for Evaluation of Response to Cancer Therapies (U01)

(PAR-14-116)
National Cancer Institute

Funding:

$500,000/yr for 5 years

Application Receipt Date(s):

Multiple dates, see announcement 


Modeling Social Behavior (R01)

(PAR-13-374)
National Cancer Institute

Funding:

Standard R01 limits apply

Deadline:

Multiple dates, see announcement.


Pancreatic Cancer Action Network Research Grants Program

Sponsor:

Pancreatic Cancer Action Network and American Association for Cancer Research

Funding is available for postdoctoral/clinical research fellows as well as for junior and senior independent researchers. The proposed research must be directly relevant to pancreatic cancer. More information about the grants program, including eligibility criteria and application due dates and procedures, is available at http://www.pancan.org/2014grants.

Funding:

See announcement

Deadlines:

Multiple; see announcement


 Research to Characterize and Reduce Stigma to Improve Health

R01 (PA-13-248), R03 (PA-13-247) and R21 (PA-13-246)

National Cancer Institute

Funding:

Standard limits apply.

Application Receipt Date(s):

Multiple dates, see announcement.  Standard cycle dates.


Prostate Cancer Research Program (PCRP)

Sponsor:

Department of Defense

Funding:

See announcements

Deadlines:

Various; see announcements


Innovative Research Methods: Prevention and Management of Symptoms in Chronic Illness

R01 (PA-13-165), R15 (PA-13-166) and R21 (PA-13-167)

National Cancer Institute

Funding:

Standard limits apply. See announcements for additional information

Application Receipt Date(s):

Multiple dates, see announcement.


Bioengineering Research Grants (BRG) (R01)

(PAR-13-137)
National Cancer Institute

Funding:

Standard R01 limits apply.

Application Deadline: 

Multiple receipt dates, see announcement.


Academic-Industrial Partnerships for Translation of in vivo Imaging Systems for Cancer Investigations (R01)

(PAR-13-169)
National Cancer Institute

Funding:

standard R01 limits apply

Application Receipt Date(s):

Multiple dates, see announcement.


Graduate Training in Disparities Research (GTDR)

Susan G. Komen

GTDR Grants are intended to establish and/or to sustain a training program for a minimum of three graduate students who are seeking careers dedicated to understanding and eliminating disparities in breast cancer outcomes across population groups. Over the past 7 years, Komen has provided funding to outstanding training programs to ensure that a diverse pool of highly trained scientists will emerge as the next generation of leaders in the field of breast cancer research focused on disparities in breast cancer outcomes. Komen supports exceptionally creative training programs for students of diverse backgrounds as a means to support innovative breast disparities research.

Funding:

Up to $135,000 per year, direct costs only, for up to 3 years.

Key Dates:

Full application due September 20, 2016

 

 

American Association for Cancer Research

​The AACR NextGen Grants for Transformative Cancer Research represent the AACR's flagship funding initiative to stimulate highly innovative research from young investigators. This grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that may not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries and help talented young investigators gain scientific independence.

Funding: The grants provide $450,000 over three years

Key dates:

Letter of intent due September 12, 2016

If invited for full application, due December 19th, 2016

 

Pancreatic Cancer Action Network-AACR Career Development Award

The Pancreatic Cancer Action Network-AACR Career Development Awards represent a joint effort to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in this field.

Funding: The grants provide $200,000 over two years.

Key dates:

Letter of intent due October 4th, 2016

If invited for full application, due January 17th, 2017

 

Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant

The Pancreatic Cancer Action Network-AACR Pathway to Leadership Grant represents a joint effort to ensure the future leadership of pancreatic cancer research by supporting outstanding early career investigators beginning in their postdoctoral research positions and continuing through their successful transition to independence. Applicants must hold a full-time, mentored research position, have completed their most recent doctoral degree or medical residency within the past five years, and not already have a full-time faculty position.

Funding: The grant provides up to five years of support, for a total of $600,000, consisting of two phases. The initial Mentored Phase is expected to last up to two years, during which time the recipient will receive $75,000 per year while working closely with a mentor(s) to develop a strong research project. During the subsequent three years, the recipient is expected to be in an independent research position and will be funded at $150,000 per year.

Key dates:

Full application due November 15th, 2016

 

RFP:Randy Shaver Cancer Research Fund

The Randy Shaver Cancer Research and Community Fund is seeking proposals from

non-profit organizations and other public entities with innovative and creative projects

that will result in benefiting Minnesota’s Cancer Community.  This fund’s primary objective

is to support organizations, hospitals, research facilities and other public entities that are

involved in cancer research, cancer patient aid and cancer oriented community endeavors.

Funding: The Fund will grant over $500,000.00 to groups/researchers that submit proposals.

Key Dates:

Full application due October 31, 2016

 

AACR Basic Cancer Research Fellowships

The AACR Basic Cancer Research Fellowships are open to postdoctoral and clinical research fellows working at an academic, medical, or research institution who have completed their most recent doctoral degree or medical residency within the past three years at the start of the grant term. The research proposed for funding may be in any area of basic cancer research.

Funding: The fellowships provide one-year grants of $50,000-$55,000

Key dates:

Letter of intent due October 11th, 2016

If invited for full application, due January 18th, 2017

 

PAR-15-332

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA focuses on early-stage development from prototyping to hardening and adaptation. Early-stage development is defined for the purpose of this FOA as the initial development or the significant modification of existing tools for new applications.

Funding: Budgets are limited to $300,000 Direct Costs per year for a maximum of 3 years.

Key Dates:

Full application due November 21, 2016.

 

Pancreatic Cancer Action Network Translational Research Grant

Supports an independent investigator leading a cross-disciplinary team conducting translational research that has as its endpoint the development of a pancreatic cancer assessment, prevention or treatment modality

Funding: $300,000 over 2 years

Key Dates:

Application due December 1st, 2016

 

Pancreatic Cancer Action Network – NCI, Frederick National Laboratory for Cancer Research KRAS Travel Scholarship

Provides travel support to a researcher at any career stage, during or after the postdoctoral level, to visit FNLCR to pursue KRAS research that is directly relevant to pancreatic cancer with aims aligned with the RAS Initiative

Funding: Depending on need

Key Dates:

Application deadline is rolling

 

Pancreatic Cancer Action Network – NCI, Frederick National Laboratory for Cancer Research KRAS Fellowship

Supports a postdoctoral or clinical research fellow to conduct KRAS research that is directly relevant to pancreatic cancer with aims aligned with the RAS Initiative

Funding: $100,000 over two years

Key Dates:

Application deadline is October 27th, 2016

 

PAR-15-334

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Initiative, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge.

Funding: Direct costs are limited to $275,000 over a two year period. No more than $200,000 may be requested in any single year.

Key Dates:

Full application due November 21, 2016

 

PAR-16-411

NCI Outstanding Investigator Award (R35)

This Funding Opportunity Announcement (FOA) invites grant applications for the Outstanding Investigator Award (R35) in any area of cancer research.

The objective of the National Cancer Institute (NCI) Outstanding Investigator Award (OIA) is to provide long-term support to accomplished investigators with outstanding records of cancer research productivity who propose to conduct exceptional research. The OIA is intended to allow investigators the opportunity to take greater risks, be more adventurous in their lines of inquiry, or take the time to develop new techniques. The OIA would allow an Institution to submit applications nominating established Program Directors/Principal Investigators (PDs/PIs) for the NCI OIA.

It is expected that the OIA would provide extended funding stability and encourage investigators to embark on projects of unusual potential in cancer research. The research projects should break new ground or extend previous discoveries toward new directions or applications that may lead to a breakthrough that will advance biomedical, behavioral, or clinical cancer research.

Funding: Awards will be for $600,000 direct costs per year, plus applicable Facilities and Administrative (F&A) costs to be determined at the time of award.

Key dates:

Full application due November 22, 2016

 

Call for Proposals: Community-University Partnership Grant Program

The Healthy Foods, Healthy Lives (HFHL) Institute has released its fall 2016 RFP for the Community-University Partnership Grant Program to fund innovative, community-University partnerships that utilize community-engaged research strategies. HFHL is also calling for Letters of Interest for the Faculty Planning Grant Program, designed to fund the development of food, nutrition, and health-related interdisciplinary faculty research teams. Submission deadline is Nov. 18. See HFHL grant opportunities >

 

Karen Wyckoff Rein in Sarcoma Foundation 2017 (LINK TO PDF)

Sarcoma Research Grant Application

The research grants support one of the three major goals of the foundation (research; patient and survivor support; and education) to continue Karen’s vision and must focus on primarily sarcoma (basic, translational, and/or clinical) research.

Funding: $50,000 for one year (cost sharing is encouraged)

Key dates:

Submission Deadline: October 31st

Review: November 2016

Funds available starting: March 1, 2017

MCC and UMN funding opportunities

Masonic Cancer Center Internal Funding Opportunities

  • Pre-R01 Pilot Grants
  • American Cancer Society’s Institutional Research Grant University of Minnesota
    Deadline: October 24, 2016
    This one-year grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. The ACS IRG award is $30,000 in direct costs to support the initiation of promising cancer-related research projects which includes cancer etiology, mechanisms of carcinogenesis and chemoprevention, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic or chemoprevention models and translational research, cancer immunology and immunotherapy.

     For information, please email Susan Fautsch, Funding Initiatives Manager, mccgrant@umn.eduOnline application link: ACS-IRG Fall 2016 Application

Other University of Minnesota Funding Opportunities

Funding resources

Federal agencies funding cancer-related research

Search funding opportunities; sign up to receive the NIH Guide weekly via e-mail.

Search for funding sources by keyword; sign up for e-mail notification of funding opportunities. (Note: NIH listings are under DHHS, the Department of Health and Human Services.)

Non-federal agencies funding cancer-related research

Research funding directories

CFDA is a database of all federal programs available to state and local governments; federally recognized Indian tribal governments; territories (and possessions) of the United States; domestic public, quasi-public, and private profit and nonprofit organizations and institutions; specialized groups; and individuals.

This funding opportunity search engine provides the world's most comprehensive funding resource, with more than 24,000 records representing nearly 400,000 opportunities ranging from local non-profit funding to federally funded grants.

This is a sortable database of current funding opportunities pulled from various databases. It boasts a user-friendly interface and a comprehensive listing. While the listing is not as comprehensive as other databases in this list, opportunities may be easier to find in this abbreviated format.

(requires x.500 login)

The premier grantseeking database on the Web, developed by the Foundation Center, a national nonprofit service organization founded over 50 years ago to open up U.S. foundations to public view.

A fee-based service, to which the University of Minnesota is a current subscriber. It currently contains over 9,000 active federal and private funding opportunities in the sciences, social sciences, arts, and humanities. In addition to funding opportunities for faculty, the IRIS Database also contains fellowships and scholarships for grad students and undergrads. Users can search IRIS by sponsor, deadline date, keyword, and other criteria. Most IRIS records contain live links to sponsor Web sites, electronic forms, or Electronic Research Administration (eRA) portals. The IRIS Database is updated daily.

InfoEd's SPIN is the most widely used funding opportunity database in the world. By aggregating sponsor information in one system, SPIN dramatically cuts search times and substantially increases the likelihood of positive results. Program information is presented in a standard format that allows investigators to readily compare opportunities. This search engine is great for post-doctoral associates looking for funding opportunities.